Regulation of oligodendrocyte progenitor cell maturation by PPARδ: Effects on bone morphogenetic proteins

ASN Neuro

Volumn 2, Issue 1, 2010, Pages 1-13

  Simonini, Maria Vittoria ^a   Polak, Paul E ^a,b   Boullerne, Anne I ^a,b   Peters, Jeffrey M ^c   Richardson, Jill C ^d   Feinstein, Douglas L ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Astrocyte; Bone morphogenetic protein (BMP); Experimental autoimmune encephalomyelitis (EAE); Multiple sclerosis; Myelin; Noggin

Indexed keywords

[4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; MESSENGER RNA; NOGGIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; CARRIER PROTEIN; NOGGIN PROTEIN; THIAZOLE DERIVATIVE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL MATURATION; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; FEMALE; MOUSE; NONHUMAN; NULL ALLELE; OLIGODENDROGLIA; PROTEIN EXPRESSION; RAT; STEM CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG POTENTIATION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODENDROGLIA; PPAR DELTA; STEM CELLS; THIAZOLES; THIAZOLIDINEDIONES;

EID: 77953367307     PISSN: None     EISSN: 17590914     Source Type: Journal    
DOI: 10.1042/AN20090033     Document Type: Article

References (69)

1. Agresti C, D'Urso D, Levi G (1996) Reversible inhibitory effects of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 8:1106-1116.
2. Ara J, See J, Mamontov P, Hahn A, Bannerman P, Pleasure D, Grinspan JB (2008) Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis. J Neurosci Res 86:125-135.
3. Basu-Modak S, Braissant O, Escher P, Desvergne B, Honegger P, Wahli W (1999) Peroxisome proliferator-activated receptor β regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures. J Biol Chem 274:35881-35888.
4. Bilican B, Fiore-Heriche C, Compston A, Allen ND, Chandran S (2008) Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level. PLoS ONE 3:e2863.
5. Chen J, Leong SY, Schachner M (2005) Differential expression of cell fate determinants in neurons and glial cells of adult mouse spinal cord after compression injury. Eur J Neurosci 22:1895-1906.
6. Cheng X, Wang Y, He Q, Qiu M, Whittemore SR, Cao Q (2007) Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells. Stem Cells 25:3204-3214.
7. Dasgupta S, Roy A, Jana M, Hartley DM, Pahan K (2007) Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-α. Mol Pharmacol 72:934-946.
8. Delerive P, De BK, Besnard S, Vanden BW, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B (1999) Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1. J Biol Chem 274:32048-32054.
9. Dello Russo C, Gavrilyuk V, Weinberg G, Almeida A, Bolanos JP, Palmer J, Pelligrino D, Galea E, Feinstein DL (2003) Peroxisome proliferator-activated receptor γ thiazolidinedione agonists increase glucose metabolism in astrocytes. J Biol Chem 278:5828-5836.
10. Deplanque D, Gele P, Petrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R (2003) Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 23:6264-6271.
11. Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK (2002) Peroxisome proliferator-activated receptor-γ agonist 15-deoxy-Δ(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. J Immunol 168:2508-2515.
12. Drew PD, Xu J, Storer PD, Chavis JA, Racke MK (2006) Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem Int 49:183-189.
13. Ekdahl CT, Kokaia Z, Lindvall O (2009) Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 158:1021-1029.
14. Feinstein DL, Galea E, Gavrilyuk V, Brosnan CF, Whitacre CC, Dumitrescu-Ozimek L, Landreth GE, Pershadsingh HA, Weinberg G, Heneka MT (2002) Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis. Ann Neurol 51:694-702.
15. Feinstein DL (2003) Therapeutic potential of peroxisome proliferatoractivated receptor agonists for neurological disease. Diabetes Technol Ther 5:67-73.
16. Feng JQ, Xing L, Zhang JH, Zhao M, Horn D, Chan J, Boyce BF, Harris SE, Mundy GR, Chen D (2003) NF-κB specifically activates BMP-2 gene expression in growth plate chondrocytes in vivo and in a chondrocyte cell line in vitro. J Biol Chem 278:29130-29135.
17. Fukui N, Ikeda Y, Ohnuki T, Hikita A, Tanaka S, Yamane S, Suzuki R, Sandell LJ, Ochi T (2006) Pro-inflammatory cytokine tumor necrosis factor-α induces bone morphogenetic protein-2 in chondrocytes via mRNA stabilization and transcriptional up-regulation. J Biol Chem 281:27229-27241.
18. Fuller ML, DeChant AK, Rothstein B, Caprariello A, Wang R, Hall AK, Miller RH (2007) Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions. Ann Neurol 62:288-300.
19. Gaughwin PM, Caldwell MA, Anderson JM, Schwiening CJ, Fawcett JW, Compston DA, Chandran S (2006) Astrocytes promote neurogenesis from oligodendrocyte precursor cells. Eur J Neurosci 23:945-956.
20. Gomes WA, Mehler MF, Kessler JA (2003) Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment. Dev Biol 255:164-177.
21. Goumans MJ, Mummery C (2000) Functional analysis of the TGFb receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44:253-265.
22. Granneman J, Skoff R, Yang X (1998) Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes. J Neurosci Res 51:563-573.
23. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17:595-606.
24. Hampton DW, Asher RA, Kondo T, Steeves JD, Ramer MS, Fawcett JW (2007a) A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 26:3024-3035.
25. Hampton DW, Steeves JD, Fawcett JW, Ramer MS (2007b) Spinally upregulated noggin suppresses axonal and dendritic plasticity following dorsal rhizotomy. Exp Neurol 204:366-379.
26. Hardy RJ, Friedrich Jr, VL (1996) Oligodendrocyte progenitors are generated throughout the embryonic mouse brain, but differentiate in restricted foci. Development 122:2059-2069.
27. Izrael M, Zhang P, Kaufman R, Shinder V, Ella R, Amit M, Itskovitz-Eldor J, Chebath J, Revel M (2007) Human oligodendrocytes derived from embryonic stem cells: effect of noggin on phenotypic differentiation in vitro and on myelination in vivo. Mol Cell Neurosci 34:310-323.
28. Kaiser CC, Shukla DK, Stebbins GT, Skias DD, Jeffery DR, Stefoski D, Katsamakis G, Feinstein DL (2009) A pilot test of pioglitazone as an addon in patients with relapsing remitting multiple sclerosis. J Neuroimmunol 211:124-130.
29. Kielian T, Drew PD (2003) Effects of peroxisome proliferator-activated receptor-γ agonists on central nervous system inflammation. J Neurosci Res 71:315-325.
30. Kilgore KS, Billin AN (2008) PPARβ/δ ligands as modulators of the inflammatory response. Curr Opin Investig Drugs 9:463-469.
31. Kliewer SA, Xu HE, Lambert MH, Willson TM (2001) Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 56:239-263.
32. Klotz L, Diehl L, Dani I, Neumann H, von Oppen N, Dolf A, Endl E, Klockgether T, Engelhardt B, Knolle P (2007) Brain endothelial PPARγ controls inflammation-induced CD4+ T cell adhesion and transmigration in vitro. J Neuroimmunol 190:34-43.
33. Kondo T, Raff MC (2004) A role for Noggin in the development of oligodendrocyte precursor cells. Dev Biol 267:242-251.
34. Lin TH, Yang RS, Tang CH, Lin CP, Fu WM (2007) PPARγ inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone 41:562-574.
35. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, Racke MK (2004) Peroxisome proliferator-activated receptor α agonists as therapy for autoimmune disease. J Immunol 172:5790-5798.
36. Mabie PC, Mehler MF, Kessler JA (1999) Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19:7077-7088.
37. Mehler MF, Mabie PC, Zhang D, Kessler JA (1997) Bone morphogenetic proteins in the nervous system. Trends Neurosci 20:309-317.
38. Mehler MF, Mabie PC, Zhu G, Gokhan S, Kessler JA (2000) Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev Neurosci 22:74-85.
39. Mekki-Dauriac S, Agius E, Kan P, Cochard P (2002) Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 129:5117-5130.
40. Michalik L, Desvergne B, Wahli W (2003) Peroxisome proliferator-activated receptors β/δ: emerging roles for a previously neglected third family member. Curr Opin Lipidol 14:129-135.
41. Mikawa S, Wang C, Sato K (2006) Bone morphogenetic protein-4 expression in the adult rat brain. J Comp Neurol 499:613-625.
42. Miller DH, MacManus DH, Miszkiel KA, Giovannoni G, Young C (2005) An exploratory study of rosiglitazone maleate in relapsing-remitting multiple sclerosis. Multiple Sclerosis 11:S164.
43. Miyazono K, Miyazawa K (2002) Id: a target of BMP signaling. Sci STKE 2002:E40.
44. Monje ML, Toda H, Palmer TD (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765.
45. Natarajan C, Bright JJ (2002) Peroxisome proliferator-activated receptor-γ agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun 3:59-70.
46. Pedraza CE, Monk R, Lei J, Hao Q, Macklin WB (2008) Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors. Glia 56:1339-1352.
47. Peretto P, Cummings D, Modena C, Behrens M, Venkatraman G, Fasolo A, Margolis FL (2002) BMP mRNA and protein expression in the developing mouse olfactory system. J Comp Neurol 451:267-278.
48. Peters JM, Lee SS, Li W, Ward JM, Gavrilova O, Everett C, Reitman ML, Hudson LD, Gonzalez FJ (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferatoractivated receptor β(δ). Mol Cell Biol 20:5119-5128.
49. Planavila A, Rodriguez-Calvo R, Jove M, Michalik L, Wahli W, Laguna JC, Vazquez-Carrera M (2005) Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res 65:832-841.
50. Pluchino S, Muzio L, Imitola J, Deleidi M, faro-Cervello C, Salani G, Porcheri C, Brambilla E, Cavasinni F, Bergamaschi A, Garcia-Verdugo JM, Comi G, Khoury SJ, Martino G (2008) Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 131:2564-2578.
51. Polak PE, Kalinin S, Dello RC, Gavrilyuk V, Sharp A, Peters JM, Richardson J, Willson TM, Weinberg G, Feinstein DL (2005) Protective effects of a peroxisome proliferator-activated receptor-β/δ agonist in experimental autoimmune encephalomyelitis. J Neuroimmunol 168:65-75.
52. Rosenberger TA, Hovda JT, Peters JM (2002) Targeted disruption of peroxisomal proliferator-activated receptor β (δ) results in distinct gender differences in mouse brain phospholipid and esterified FA levels. Lipids 37:495-500.
53. Saluja I, Granneman JG, Skoff RP (2001) PPARd agonists stimulate oligodendrocyte differentiation in tissue culture. Glia 33:191-204.
54. Samanta J, Kessler JA (2004) Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation. Development 131:4131-4142.
55. See JM, Grinspan JB (2009) Sending mixed signals: bone morphogenetic protein in myelination and demyelination J. Neuropathol Exp Neurol 68:595-604.
56. Smeets PJ, Teunissen BE, Planavila A, de Vogel-van den Bosch H, Willemsen PH, van der Vusse GJ, van Bilsen M (2008) Inflammatory pathways are activated during cardiomyocyte hypertrophy and attenuated by peroxisome proliferator-activated receptors PPARα and PPARδ. J Biol Chem 283:29109-29118.
57. Sznaidman ML, Haffner CD, Maloney PR, Fivush A, Chao E, Goreham D, Sierra ML, LeGrumelec C, Xu HE, Montana VG, Lambert MH, Willson TM, Oliver WR, Sternbach DD (2003) Novel selective small molecule agonists for peroxisome proliferator-activated receptor δ (PPARδ)-synthesis and biological activity. Bioorg Med Chem Lett 13:1517-1521.
58. Takeda M, Otsuka F, Otani H, Inagaki K, Miyoshi T, Suzuki J, Mimura Y, Ogura T, Makino H (2007) Effects of peroxisome proliferator-activated receptor activation on gonadotropin transcription and cell mitosis induced by bone morphogenetic proteins in mouse gonadotrope LβT2 cells. J Endocrinol 194:87-99.
59. Talbott JF, Cao Q, Enzmann GU, Benton RL, Achim V, Cheng XX, Mills MD, Rao MS, Whittemore SR (2006) Schwann cell-like differentiation by adult oligodendrocyte precursor cells following engraftment into the demyelinated spinal cord is BMP-dependent. Glia 54:147-159.
60. ten Dijke P, Korchynskyi O, Valdimarsdottir G, Goumans MJ (2003) Controlling cell fate by bone morphogenetic protein receptors. Mol Cell Endocrinol 211:105-113.
61. Whitney NP, Eidem TM, Peng H, Huang Y, Zheng JC (2009) Inflammation mediates varying effects in neurogenesis: Relevance to the pathogenesis of brain injury and neurodegenerative disorders. J Neurochem 108:1343-1359.
62. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, Clark AF (2002) Expression of bone morphogenetic proteins (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 8:241-250.
63. Xin H, Li Y, Chen X, Chopp M (2006) Bone marrow stromal cells induce BMP2/4 production in oxygen-glucose-deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells. J Neurosci Res 83:1485-1493.
64. Xu J, Storer PD, Chavis JA, Racke MK, Drew PD (2005) Agonists for the peroxisome proliferator-activated receptor-α and the retinoid X receptor inhibit inflammatory responses of microglia. J Neurosci Res 81:403-411.
65. Xu J, Chavis JA, Racke MK, Drew PD (2006) Peroxisome proliferator- activated receptor-a and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. J Neuroimmunol 176:95-105.
66. Xu J, Racke MK, Drew PD (2007) Peroxisome proliferator-activated receptor-α agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis. J Neurochem 103:1801-1810.
67. Yanagita M (2005) BMP antagonists: their roles in development and involvement in pathophysiology. Cytokine Growth Factor Rev 16:309-317.
68. Zhang M, Zhou SH, Zhao S, Li XP, Liu LP, Shen XQ (2008) Pioglitazone can downregulate bone morphogenetic protein-2 expression induced by high glucose in human umbilical vein endothelial cells. Pharmacology 81:312-316.
69. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400:687-693.